JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB125025

Anti-ROCK2 antibody [EPR7141(B)]

  • 20ul selling size
  • RabMAb
  • Recombinant
  • KO Validated
  • What is this?

4

(4 Reviews)

|

(62 Publications)

Rabbit Recombinant Monoclonal ROCK2 antibody. Suitable for WB, ICC/IF and reacts with Mouse, Rat, Human samples. Cited in 62 publications.

View Alternative Names

KIAA0619, ROCK2, Rho-associated protein kinase 2, Rho kinase 2, p164 ROCK-2, ROCK-II

8 Images
Immunocytochemistry/ Immunofluorescence - Anti-ROCK2 antibody [EPR7141(B)] (AB125025)
  • ICC/IF

Unknown

Immunocytochemistry/ Immunofluorescence - Anti-ROCK2 antibody [EPR7141(B)] (AB125025)

Immunocytochemistry/Immunofluorescence analysis of HeLa (human cervix adenocarcinoma) cells labelling ROCK2 with purified ab125025 at 1/250. Cells were fixed with 4% Paraformaldehyde and permeabilized with 0.1% Triton X-100. ab150077, Alexa Fluor® 488-conjugated goat anti-rabbit IgG (1/1000) was used as the secondary antibody. Cells were counter-stained with ab7291 anti-Tubulin (mouse mAb) primary and ab150120 (AlexaFluor®594 goat anti-mouse) secondary both at 1/1000 dilution. Nuclei were counterstained with DAPI (blue).

For negative control 1, rabbit primary antibody and ab150120 (anti-mouse) secondary antibody were used. For negative control 2, ab7291 (mouse primary antibody) was used followed by ab150077 (anti-rabbit secondary antibody).

Western blot - Anti-ROCK2 antibody [EPR7141(B)] (AB125025)
  • WB

Unknown

Western blot - Anti-ROCK2 antibody [EPR7141(B)] (AB125025)

All lanes:

Western blot - Anti-ROCK2 antibody [EPR7141(B)] (ab125025) at 1/10000 dilution

Lane 1:

Hela cell lysate at 10 µg

Lane 2:

L6 cell lysate at 10 µg

Lane 3:

A673 cell lysate at 10 µg

Secondary

All lanes:

HRP labelled goat anti-rabbit at 1/2000 dilution

Predicted band size: 161 kDa

false

Western blot - Anti-ROCK2 antibody [EPR7141(B)] (AB125025)
  • WB

Lab

Western blot - Anti-ROCK2 antibody [EPR7141(B)] (AB125025)

Lanes 1- 4 : Merged signal (red and green). Green - ab125025 observed at 175 kDa. Red - Anti-GAPDH antibody [6C5] - Loading Control (ab8245) observed at 37 kDa.

ab125025 was shown to react with ROCK2 in wild-type HeLa cells in western blot. Loss of signal was observed when knockout cell line ab265679 (knockout cell lysate ab257643) was used. Wild-type HeLa and ROCK2 knockout HeLa cell lysates were subjected to SDS-PAGE. Membrane was blocked for 1 hour at room temperature in 0.1% TBST with 3% non-fat dried milk. ab125025 and Anti-GAPDH antibody [6C5] - Loading Control (ab8245) overnight at 4°C at a 1 in 10000 dilution and a 1 in 20000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye®800CW) preadsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye®680RD) preadsorbed (ab216776) secondary antibodies at 1 in 20000 dilution for 1 hour at room temperature before imaging.

All lanes:

Western blot - Anti-ROCK2 antibody [EPR7141(B)] (ab125025) at 1/10000 dilution

Lane 1:

Wild-type HeLa cell lysate at 20 µg

Lane 2:

ROCK2 knockout HeLa cell lysate at 20 µg

Lane 2:

Western blot - Human ROCK2 knockout HeLa cell line (<a href='/en-us/products/cell-lines/human-rock2-knockout-hela-cell-line-ab265679'>ab265679</a>)

Lane 3:

HepG2 cell lysate at 20 µg

Lane 4:

A549 cell lysate at 20 µg

Predicted band size: 161 kDa

Observed band size: 175 kDa

false

Western blot - Anti-ROCK2 antibody [EPR7141(B)] (AB125025)
  • WB

Lab

Western blot - Anti-ROCK2 antibody [EPR7141(B)] (AB125025)

Lane 1 : Wild-type HAP1 cell lysate (20 μg)
Lane 2 : ROCK2 knockout HAP1 cell lysate (20 μg)
Lane 3 : HeLa cell lysate (20 μg)
Lane 4 : A10 cell lysate (20 μg)
Lanes 1 - 4 : Merged signal (red and green). Green - ab125025 observed at 165 kDa. Red - loading control, ab8245, observed at 37 kDa.

ab125025 was shown to specifically react with ROCK2 when ROCK2 knockout samples were used. Wild-type and ROCK2 knockout samples were subjected to SDS-PAGE. ab125025 and ab8245 (loading control to GAPDH) were diluted 1/10 000 and 1/2000 respectively and incubated overnight at 4°C. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preadsorbed (ab216776) secondary antibodies at 1/10,000 dilution for 1 h at room temperature before imaging.

All lanes:

Western blot - Anti-ROCK2 antibody [EPR7141(B)] (ab125025)

Predicted band size: 161 kDa

false

Western blot - Anti-ROCK2 antibody [EPR7141(B)] (AB125025)
  • WB

Unknown

Western blot - Anti-ROCK2 antibody [EPR7141(B)] (AB125025)

Blocking and Diluting buffer 5% NFDM/TBST

All lanes:

Western blot - Anti-ROCK2 antibody [EPR7141(B)] (ab125025) at 1/50000 dilution

Lane 1:

HeLa whole cell lysate at 10 µg

Lane 2:

HEK293 whole cell lysate at 10 µg

Lane 3:

Mouse brain tissue lysate at 10 µg

Lane 4:

Rat brain tissue lysate at 10 µg

Secondary

All lanes:

Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution

Predicted band size: 161 kDa

Observed band size: 161 kDa

false

Western blot - Anti-ROCK2 antibody [EPR7141(B)] (AB125025)
  • WB

Unknown

Western blot - Anti-ROCK2 antibody [EPR7141(B)] (AB125025)

Blocking and Diluting buffer 5% NFDM/TBST

All lanes:

Western blot - Anti-ROCK2 antibody [EPR7141(B)] (ab125025) at 1/10000 dilution

All lanes:

RAW264.7 whole cell lysate at 10 µg

Secondary

All lanes:

Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution

Predicted band size: 161 kDa,305 kDa

Observed band size: 161 kDa

false

OI-RD Scanning - Anti-ROCK2 antibody [EPR7141(B)] (AB125025)
  • OI-RD Scanning

Unknown

OI-RD Scanning - Anti-ROCK2 antibody [EPR7141(B)] (AB125025)

We have systematically measured KD (the equilibrium dissociation constant between the antibody and its antigen), of more than 840 recombinant antibodies to assess not only their individual KD values but also to see the average affinity of antibody. Based on the comparison with published literature values for mouse monoclonal antibodies, Recombinant antibodies appear to be on average 1-2 order of magnitude higher affinity.

Western blot - Anti-ROCK2 antibody [EPR7141(B)] (AB125025)
  • WB

CiteAb

Western blot - Anti-ROCK2 antibody [EPR7141(B)] (AB125025)

ROCK2 western blot using anti-ROCK2 antibody [EPR7141(B)] ab125025. Publication image and figure legend from Li, M. Z., Zhan, Y., et al., 2020, Front Physiol, PubMed 31920724.

ab125025 was used in this publication in western blot. This may not be the same as the application(s) guaranteed by Abcam. For a full list of applications guaranteed by Abcam for ab125025 please see the product overview.

Effect of XSEC or EE and their combination on the expressions of GAP-43, NogoA/NgR and RhoA/ROCK2 in MCAO rats. Quantitative analysis of the protein (A,C,E) and mRNA (B,D,F) levels of GAP-43, NogoA/NgR, and RhoA/ROCK2, respectively (one-way ANOVA followed by Bonferroni's post hoc test, n = 4 per group). #p < 0.05, ##p < 0.01, ###p < 0.001 vs. control group. *p < 0.05, **p < 0.01, ***p < 0.001 vs. vehicle group.

false

Key facts

Host species

Rabbit

Clonality

Monoclonal

Clone number

EPR7141(B)

Isotype

IgG

Carrier free

No

Reacts with

Mouse, Rat, Human

Applications

WB, ICC/IF

applications

Immunogen

The exact immunogen used to generate this antibody is proprietary information.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"}, "ICCIF" : {"fullname" : "Immunocytochemistry/ Immunofluorescence", "shortname":"ICC/IF"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/10000 - 1/50000", "WB-species-notes": "<p></p>", "IHCP-species-checked": "notRecommended", "IHCP-species-dilution-info": "1/50 - 1/100", "IHCP-species-notes": "<p></p>", "ICCIF-species-checked": "testedAndGuaranteed", "ICCIF-species-dilution-info": "1/100 - 1/250", "ICCIF-species-notes": "<p></p>" }, "Mouse": { "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/10000 - 1/50000", "WB-species-notes": "<p></p>", "IHCP-species-checked": "notRecommended", "IHCP-species-dilution-info": "1/50 - 1/100", "IHCP-species-notes": "<p></p>", "ICCIF-species-checked": "guaranteed", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "" }, "Rat": { "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/10000 - 1/50000", "WB-species-notes": "<p></p>", "IHCP-species-checked": "notRecommended", "IHCP-species-dilution-info": "1/50 - 1/100", "IHCP-species-notes": "<p></p>", "ICCIF-species-checked": "guaranteed", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "" } } }

Product details

Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:

  • - High batch-to-batch consistency and reproducibility
  • - Improved sensitivity and specificity
  • - Long-term security of supply
  • - Animal-free batch production

For more information, read more on recombinant antibodies.

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Protein A
Storage buffer
pH: 7.2 - 7.4 Preservative: 0.01% Sodium azide Constituents: PBS, 40% Glycerol (glycerin, glycerine), 0.14% BSA
Shipped at conditions
Blue Ice
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Protein kinase which is a key regulator of actin cytoskeleton and cell polarity. Involved in regulation of smooth muscle contraction, actin cytoskeleton organization, stress fiber and focal adhesion formation, neurite retraction, cell adhesion and motility via phosphorylation of ADD1, BRCA2, CNN1, EZR, DPYSL2, EP300, MSN, MYL9/MLC2, NPM1, RDX, PPP1R12A and VIM. Phosphorylates SORL1 and IRF4. Acts as a negative regulator of VEGF-induced angiogenic endothelial cell activation. Positively regulates the activation of p42/MAPK1-p44/MAPK3 and of p90RSK/RPS6KA1 during myogenic differentiation. Plays an important role in the timely initiation of centrosome duplication. Inhibits keratinocyte terminal differentiation. May regulate closure of the eyelids and ventral body wall through organization of actomyosin bundles. Plays a critical role in the regulation of spine and synaptic properties in the hippocampus. Plays an important role in generating the circadian rhythm of the aortic myofilament Ca(2+) sensitivity and vascular contractility by modulating the myosin light chain phosphorylation.
See full target information ROCK2

Publications (62)

Recent publications for all applications. Explore the full list and refine your search

Cell death & disease 16:380 PubMed40368918

2025

Extracellular matrix stiffness in endometrial cancer: driving progression and modulating treatment sensitivity via the ROCK1/YAP1 axis.

Applications

Unspecified application

Species

Unspecified reactive species

Rui Sun,Ying Zhao,Yao Liu,Mengyao Zhang,Ziyi Qiu,Xiaohong Ma,Lina Wei,Wei Lu,Zhiming Liu,Jie Jiang

The FEBS journal 292:776-795 PubMed39632420

2024

Coordination among cytoskeletal organization, cell contraction, and extracellular matrix development is dependent on LOX for aneurysm prevention.

Applications

Unspecified application

Species

Unspecified reactive species

Rohtem Aviram,Shelly Zaffryar-Eilot,Anna Kaganovsky,Anas Odeh,Shay Melamed,Ruslana Militsin,Lavi Coren,Cameron B Pinnock,Ariel Shemesh,Raz Palty,Santhi K Ganesh,Peleg Hasson

Cell death and differentiation 31:1611-1624 PubMed39406918

2024

AKR1B1-dependent fructose metabolism enhances malignancy of cancer cells.

Applications

Unspecified application

Species

Unspecified reactive species

Qing Zhao,Bing Han,Lu Wang,Jia Wu,Siliang Wang,Zhenxing Ren,Shouli Wang,Haining Yang,Michele Carbone,Changsheng Dong,Gerry Melino,Wen-Lian Chen,Wei Jia

Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism 44:1238-1252 PubMed38833563

2024

The novel ROCK2 selective inhibitor NRL-1049 preserves the blood-brain barrier after acute injury.

Applications

Unspecified application

Species

Unspecified reactive species

Inge A Mulder,Matt Abbinanti,Sarah A Woller,Joerg Ruschel,Jonathan M Coutinho,Helga E de Vries,Ed van Bavel,Kenneth Rosen,Lisa McKerracher,Cenk Ayata

Inflammation 47:1520-1535 PubMed38436811

2024

A New Modulator of Neuroinflammation in Diabetic Retinopathy: USP25.

Applications

Unspecified application

Species

Unspecified reactive species

Qiang Hu,Xue Zhang,Hongsong Peng,Jitian Guan,Zhangxin Huang,Bo Jiang,Dawei Sun

Journal of clinical and translational hepatology 12:36-51 PubMed38250467

2024

Artesunate Induces Ferroptosis in Hepatic Stellate Cells and Alleviates Liver Fibrosis via the ROCK1/ATF3 Axis.

Applications

Unspecified application

Species

Unspecified reactive species

Yingqian Wang,Yujia Li,Yangling Qiu,Min Shen,Ling Wang,Jiangjuan Shao,Feng Zhang,Xuefen Xu,Zili Zhang,Mei Guo,Shizhong Zheng

Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences 32:11-24 PubMed37926762

2023

Chidamide inhibits cell glycolysis in acute myeloid leukemia by decreasing N6-methyladenosine-related GNAS-AS1.

Applications

Unspecified application

Species

Unspecified reactive species

Changmei Hu,Xiao Fu,Shujun Li,Cong Chen,Xielan Zhao,Jie Peng

Biological research 56:52 PubMed37789455

2023

Focal ischemic stroke modifies microglia-derived exosomal miRNAs: potential role of mir-212-5p in neuronal protection and functional recovery.

Applications

Unspecified application

Species

Unspecified reactive species

Si-Si Li,Jia-Jia Wu,Xiang-Xin Xing,Yu-Lin Li,Jie Ma,Yu-Jie Duan,Jun-Peng Zhang,Chun-Lei Shan,Xu-Yun Hua,Mou-Xiong Zheng,Jian-Guang Xu

Epigenetics 18:2239592 PubMed37566742

2023

ZNF143 inhibits hepatocyte mitophagy and promotes non-alcoholic fatty liver disease by targeting increased lncRNA NEAT1 expression to activate ROCK2 pathway.

Applications

Unspecified application

Species

Unspecified reactive species

Yujie Dong,Minjie Hu,Kewei Tan,Rongjuan Dai

Proceedings of the National Academy of Sciences of the United States of America 120:e2210735120 PubMed37075074

2023

Rapid cancer cell perineural invasion utilizes amoeboid migration.

Applications

Unspecified application

Species

Unspecified reactive species

Andrea R Marcadis,Elizabeth Kao,Qi Wang,Chun-Hao Chen,Laxmi Gusain,Ann Powers,Richard L Bakst,Sylvie Deborde,Richard J Wong
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com